Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of products in various therapeutic areas, such as anti-biotics, cardiovascular diseases and gastro-intestinal tract disorders, anti-infectives, alimentary tract and metabolism, genito-urinary system, nervous system, blood forming organs, weight management, and sex hormones. The company was incorporated in 1986 and is based in 6th of October City, Egypt.
Metrics to compare | RMDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRMDAPeersSector | |
---|---|---|---|---|
P/E Ratio | 17.5x | 10.5x | −0.5x | |
PEG Ratio | 0.22 | 0.02 | 0.00 | |
Price/Book | 3.2x | 2.0x | 2.6x | |
Price / LTM Sales | 2.1x | 1.5x | 3.3x | |
Upside (Analyst Target) | 56.7% | 9.5% | 43.5% | |
Fair Value Upside | Unlock | 12.4% | 6.8% | Unlock |